Drew Holmes is currently a Patent Attorney at Novartis Pharmaceuticals Corporation in New Jersey, where he is a member of the Neuroscience/Ophthalmics Team.
Drew holds a Bachelor of Science in Microbiology from the University of Miami (Florida) and a Ph.D. in Microbiology and Molecular Genetics from Rutgers University and the University of Medicine & Dentistry of New Jersey. He received his law degree from the Fordham University Law School in New York City and is licensed to practice in New York, Connecticut, New Jersey (special limited license for in-house counsel) and before the United States Patent and Trademark Office.
Prior to joining Novartis, Drew was in private practice at Darby & Darby, P.C., an IP boutique based in New York City, where he handled prosecution, opinion, and litigation matters. His previous experience includes one year as a litigator with Greenberg Traurig in New York, and four years at Fish & Neave, also in New York, where he handled prosecution, opinion, and litigation matters.
At Novartis, Drew has a broad-based intellectual property practice involving litigation, patent counseling and procurement, and transactional matters. Drew provides patent counseling in the areas of chemistry, biology, biotechnology, biochemistry, molecular biology, immunology, and virology. Drew also manages Neuroscience due diligence inquiries on behalf of the Legal Intellectual Property Department.